Processa Pharmaceuticals Inc (PCSA)
1.67
+0.13
(+8.44%)
USD |
NASDAQ |
Apr 17, 16:00
1.66
-0.01
(-0.60%)
After-Hours: 05:44
Processa Pharmaceuticals Price: 1.67 for April 17, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 17, 2024 | 1.53 | 1.707 | 1.53 | 1.67 | 75232.00 |
Apr 16, 2024 | 1.52 | 1.56 | 1.40 | 1.54 | 101881.0 |
Apr 15, 2024 | 1.62 | 1.65 | 1.49 | 1.515 | 131557.0 |
Apr 12, 2024 | 1.67 | 1.78 | 1.63 | 1.67 | 64886.00 |
Apr 11, 2024 | 1.83 | 1.89 | 1.66 | 1.76 | 686961.0 |
Apr 10, 2024 | 2.89 | 2.90 | 1.45 | 1.84 | 1.288M |
Apr 09, 2024 | 3.00 | 3.305 | 2.90 | 2.91 | 626896.0 |
Apr 08, 2024 | 2.85 | 3.05 | 2.56 | 2.985 | 401327.0 |
Apr 05, 2024 | 2.41 | 2.94 | 2.30 | 2.79 | 922459.0 |
Apr 04, 2024 | 2.32 | 2.554 | 2.28 | 2.32 | 317622.0 |
Apr 03, 2024 | 2.62 | 2.62 | 2.25 | 2.36 | 445175.0 |
Apr 02, 2024 | 2.30 | 3.170 | 2.27 | 2.54 | 2.985M |
Apr 01, 2024 | 2.38 | 2.443 | 2.28 | 2.35 | 157561.0 |
Mar 28, 2024 | 2.34 | 2.46 | 2.27 | 2.365 | 166036.0 |
Mar 27, 2024 | 2.19 | 2.426 | 2.15 | 2.27 | 145716.0 |
Mar 26, 2024 | 2.22 | 2.24 | 2.129 | 2.17 | 55159.00 |
Mar 25, 2024 | 2.29 | 2.29 | 2.16 | 2.25 | 31070.00 |
Mar 22, 2024 | 2.19 | 2.252 | 2.16 | 2.24 | 30386.00 |
Mar 21, 2024 | 2.25 | 2.25 | 2.08 | 2.17 | 49836.00 |
Mar 20, 2024 | 2.22 | 2.28 | 2.20 | 2.23 | 32561.00 |
Mar 19, 2024 | 2.22 | 2.28 | 2.204 | 2.26 | 25886.00 |
Mar 18, 2024 | 2.20 | 2.29 | 2.16 | 2.29 | 40392.00 |
Mar 15, 2024 | 2.25 | 2.26 | 2.19 | 2.19 | 32700.00 |
Mar 14, 2024 | 2.26 | 2.285 | 2.22 | 2.23 | 49730.00 |
Mar 13, 2024 | 2.292 | 2.34 | 2.24 | 2.29 | 33249.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.515
Minimum
Apr 15 2024
263.00
Maximum
Mar 18 2021
70.10
Average
57.40
Median
Apr 18 2022
Price Benchmarks
Panbela Therapeutics Inc | 0.516 |
Vera Therapeutics Inc | 40.02 |
Corbus Pharmaceuticals Holdings Inc | 37.13 |
Ensysce Biosciences Inc | 0.6298 |
Elicio Therapeutics Inc | 9.19 |
Price Related Metrics
Price to Book Value | 0.956 |
Earnings Yield | -531.7% |
Market Cap | 4.770M |